Science Explorer Interactive view Map
Hospital / health system · Kamenica · Serbia

Institute for Pulmonary Diseases of Vojvodina

In research, Institute for Pulmonary Diseases of Vojvodina stands highest in Health Sciences (#10,745 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine and Medicine — Pulmonary and Respiratory Medicine is 18.6× its share of world research.

World rank, 2022–2025
#17,427
of 28,054 · #29,093 all time
Rank in Serbia
#33
of 71
Research works
422
▼ 28% vs 2013–17
Citations
2.7k
6.3 per fractional work
Top-10% rate
6.8%
record average 16.5%
Open access
59%
world 28%

What is Institute for Pulmonary Diseases of Vojvodina known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #10,745 of 11,982 5.5%63 #13231

Each strip is that field’s whole ranked pool, with the notch where Institute for Pulmonary Diseases of Vojvodina sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Institute for Pulmonary Diseases of Vojvodina specialise in?

Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 18.6× the share of its output that it takes of world research.

  1. Pulmonary and Respiratory MedicineSubfield · 21.8 works19×
  2. MedicineField · 59.3 works4.0×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.79× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 2.61× its world share, 2 worksImmunology and Micro…Neuroscience: 0.60× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.82× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.01× its world share, 0 worksComputer ScienceEngineering: 0.07× its world share, 1 worksEngineeringEnvironmental Science: 0.51× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyDentistry: 1.50× its world share, 1 worksDentistryHealth Professions: 1.26× its world share, 2 worksHealth ProfessionsMedicine: 4.03× its world share, 59 worksMedicineNursing: 1.15× its world share, 0 worksNursingVeterinary: 3.21× its world share, 0 worksVeterinaryArts and Humanities: 0.45× its world share, 1 worksArts and HumanitiesDecision Sciences: 0.47× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.18× its world share, 0 worksEconomics, Econometr…Psychology: 0.42× its world share, 1 worksPsychologySocial Sciences: 0.12× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Who are the top researchers at Institute for Pulmonary Diseases of Vojvodina?

Ranked on the composite score, Branislava Milenković lead among researchers whose main affiliation is Institute for Pulmonary Diseases of Vojvodina.

  1. 1 Branislava Milenković Serbia · #302,462 worldwide 73 citations · 30 works
All ranked researchers at Institute for Pulmonary Diseases of Vojvodina

Which keywords describe research at Institute for Pulmonary Diseases of Vojvodina?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Diagnosis, Clinical Trials, Radiotherapy, Adjuvant Therapy, Targeted Therapy, Lung Cancer and CT Screening.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy9▲ 16×15 topics
  2. Epidemiology8▲ 2.8×38 topics
  3. Diagnosis7▲ 9.5×16 topics
  4. Clinical Trials7▲ 13×8 topics
  5. Radiotherapy6▲ 21×5 topics
  6. Inflammation6▲ 3.7×24 topics
  7. Adjuvant Therapy6▲ 58×2 topics
  8. Targeted Therapy6▲ 33×4 topics
  9. CT Screening6▲ 106×1 topic
  10. Lung Cancer6▲ 42×2 topics
  11. Tumor Staging6▲ 65×1 topic
  12. Management5▲ 8.6×12 topics
  13. Treatment5▲ 5.5×19 topics
  14. Treatment Guidelines5▲ 28×2 topics
  15. Risk Factors4▲ 5.0×13 topics
  16. ALK Inhibitors4▲ 84×1 topic
  17. EGFR Mutations4▲ 84×1 topic
  18. Global Burden4▲ 8.4×5 topics
  19. Clinical Practice Guidelines3▲ 7.3×12 topics
  20. Cardiovascular Disease3▲ 3.5×15 topics
  21. Immunotherapy3▲ 5.0×9 topics
  22. Mechanical Ventilation3▲ 31×2 topics
  23. COPD3▲ 51×1 topic
  24. Mortality3▲ 5.9×8 topics
  25. spirometry3▲ 51×1 topic
  26. Fibrosis2▲ 17×2 topics
  27. Interstitial Lung Disease2▲ 50×2 topics
  28. Idiopathic Pulmonary Fibrosis2▲ 67×1 topic
  29. TGF-ß2▲ 20×1 topic
  30. Depression2▲ 3.2×8 topics
  31. Metastasis2▲ 8.3×5 topics
  32. Biomarkers2▲ 4.0×5 topics
  33. Immune Response2▲ 4.6×8 topics
  34. Prognosis2▲ 7.9×6 topics
  35. Prognostic Factors2▲ 5.4×5 topics
  36. Antithrombotic Therapy2▲ 28×1 topic
  37. Venous Thromboembolism2▲ 36×1 topic
  38. Acute Lung Injury2▲ 37×1 topic
  39. Acute Respiratory Distress Syndrome2▲ 37×1 topic
  40. Thrombosis2▲ 7.5×5 topics

Which research topics does Institute for Pulmonary Diseases of Vojvodina publish most on?

By volume in 2022–2025: Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Chronic Obstructive Pulmonary Disease (COPD) Research and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

  1. 1 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 6 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  3. 3 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 3 works
  4. 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 2 works
  5. 5 Venous Thromboembolism Diagnosis and Management Internal Medicine 2 works
  6. 6 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 2 works
  7. 7 Lung Cancer Research Studies Oncology 1 works
  8. 8 Asthma and respiratory diseases Physiology 1 works
  9. 9 Nutrition and Health in Aging Physiology 1 works
  10. 10 Tracheal and airway disorders Pulmonary and Respiratory Medicine 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.7%not open41.3%

World: 28% of research is openly available.

with international co-authors18.0%domestic only82.0%

World: 19% is written across borders.

How has Institute for Pulmonary Diseases of Vojvodina's research output changed?

Output in 2018–2022 was 28% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Kamenica

All research institutions in Kamenica

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.